Luigi Mazzeo

A Combination of Approved Antibodies Overcomes Resistance of Lung Cancer to Osimertinib by Blocking Bypass Pathways

T. Salame, Y. Yarden, A. Onn, 2018, Clinical Cancer Research.

An oligoclonal antibody durably overcomes resistance of lung cancer to third‐generation EGFR inhibitors

T. Salame, Y. Yarden, J. Downward, 2017, EMBO molecular medicine.